Latest astrocytoma Stories
Following Meeting with FDA, Company Advances Towards Pivotal Phase 2/3 Trial in Patients with Recurrent High Grade Glioma WASHINGTON, May 4, 2015 /PRNewswire/ --
SAN DIEGO, April 30, 2015 /PRNewswire/ -- Tocagen Inc., a clinical-stage immuno-oncology company, today announced updated
CALGARY, April 17, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
RnRMarketResearch.com adds “Malignant Glioma – Pipeline Review, H1 2015” report to its store.
- Data include results from a Phase 1 study of ABT-414 as monotherapy and in combination with radiation and/or chemotherapy in patients with newly diagnosed and recurrent/unresectable glioblastoma
- Results from Phase I program in glioblastoma multiforme presented at ASCO earlier this year NORTH CHICAGO, Ill., Aug.
Brian Olson Discusses Diagnosis, Importance of Patient Resources and Support Chicago, IL (PRWEB) July 25, 2014 There are 700,000 people in the U.S.
("Leading Edge" Gamma Knife Treatment, led by Christopher Duma, M.D., FACS and his team of researchers, offers hope to patients with Glioblastoma Multiforme) NEWPORT BEACH, Calif.,
HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc.
Neurosurgeon Peter Nakaji has published four academic papers with colleagues, each discussing technology and the intraoperative diagnosis of brain tumors. Phoenix,
- A woman chauffeur.
- A woman who operates an automobile.